These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6139625)

  • 21. Models of phage growth and their applicability to phage therapy.
    Weld RJ; Butts C; Heinemann JA
    J Theor Biol; 2004 Mar; 227(1):1-11. PubMed ID: 14969703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage therapy--advantages over antibiotics?
    Pirisi A
    Lancet; 2000 Oct; 356(9239):1418. PubMed ID: 11052592
    [No Abstract]   [Full Text] [Related]  

  • 23. Bacteriophage therapy.
    Summers WC
    Annu Rev Microbiol; 2001; 55():437-51. PubMed ID: 11544363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is phage therapy acceptable in the immunocompromised host?
    Borysowski J; Górski A
    Int J Infect Dis; 2008 Sep; 12(5):466-71. PubMed ID: 18400541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections.
    Sulakvelidze A
    Drug Discov Today; 2005 Jun; 10(12):807-9. PubMed ID: 15970258
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
    Ryan EM; Gorman SP; Donnelly RF; Gilmore BF
    J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T4 phages against Escherichia coli diarrhea: potential and problems.
    Denou E; Bruttin A; Barretto C; Ngom-Bru C; Brüssow H; Zuber S
    Virology; 2009 May; 388(1):21-30. PubMed ID: 19339031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice.
    Tanji Y; Shimada T; Fukudomi H; Miyanaga K; Nakai Y; Unno H
    J Biosci Bioeng; 2005 Sep; 100(3):280-7. PubMed ID: 16243277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New dawn for phage therapy.
    Dixon B
    Lancet Infect Dis; 2004 Mar; 4(3):186. PubMed ID: 14998510
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
    Golkar Z; Bagasra O; Pace DG
    J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacteriophages as antibacterial agents].
    Shasha SM; Sharon N; Inbar M
    Harefuah; 2004 Feb; 143(2):121-5, 166. PubMed ID: 15143702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [EFFECT OF SPECIFIC BACTERIOPHAGE ON ENTEROPATHOGENIC ESCHERICHIA COLI 0111:B4 IN THE BODY OF WHITE MICE].
    ZAKHAROVA RI
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Jun; 40():108-13. PubMed ID: 14073920
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of bacteriophage preparations on migration of HL-60 leukemia cells in vitro.
    Kurzepa-Skaradzinska A; Skaradzinski G; Weber-Dabrowska B; Zaczek M; Maj T; Slawek A; Switalska M; Maciejewska M; Wietrzyk J; Rymowicz W; Gorski A
    Anticancer Res; 2013 Apr; 33(4):1569-74. PubMed ID: 23564799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of bacteriophage therapy in surgical practice].
    Lakhno VM; Bordunovskiĭ VN
    Vestn Khir Im I I Grek; 2001; 160(1):122-5. PubMed ID: 11258316
    [No Abstract]   [Full Text] [Related]  

  • 36. Bacteriophages displaying anticancer peptides in combined antibacterial and anticancer treatment.
    Dąbrowska K; Kaźmierczak Z; Majewska J; Miernikiewicz P; Piotrowicz A; Wietrzyk J; Lecion D; Hodyra K; Nasulewicz-Goldeman A; Owczarek B; Górski A
    Future Microbiol; 2014; 9(7):861-9. PubMed ID: 25156375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage cocktails and the future of phage therapy.
    Chan BK; Abedon ST; Loc-Carrillo C
    Future Microbiol; 2013 Jun; 8(6):769-83. PubMed ID: 23701332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals.
    Payne RJ; Phil D; Jansen VA
    Clin Pharmacol Ther; 2000 Sep; 68(3):225-30. PubMed ID: 11014403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of phage-mediated biocontrol of bacteria.
    Abedon ST
    Foodborne Pathog Dis; 2009 Sep; 6(7):807-15. PubMed ID: 19459758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.
    Ahmad SI
    Med Hypotheses; 2002 Apr; 58(4):327-31. PubMed ID: 12027527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.